Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700785 · ClinicalTrials.gov registry record · NA
A Pharmacokinetic Comparison of Three Butyrate Products
A NA study, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT06700785: Completed NA study, sponsored by The Center for Applied Health Sciences.
NCT06700785 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06700785, a NA study, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is a randomized, three-arm, interventional study of N=10 apparently healthy men. This study will quantify plasma butyrate responses to a single dose of three different butyrate products.
Primary Outcome
Plasma butyrate levels in ug/mL.
Interventions
- DIETARY_SUPPLEMENT Lysine butyrate
- DIETARY_SUPPLEMENT Sodium Butyrate
- DIETARY_SUPPLEMENT Tributyrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-05-03 |
| Est. Completion | 2024-09-12 |
| Phase | NA |
What the finished NCT06700785 record still lists
NCT06700785 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Lysine butyrate is the first listed.
NCT06700785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06700785 about?
NCT06700785 is a clinical study titled "A Pharmacokinetic Comparison of Three Butyrate Products". This study is a randomized, three-arm, interventional study of N=10 apparently healthy men. This study will quantify plasma butyrate responses to a single dose of three different butyrate products.
What is the current status of trial NCT06700785?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-05-03. Estimated completion is 2024-09-12.
What interventions are being tested in trial NCT06700785?
The interventions under investigation include: Lysine butyrate (DIETARY_SUPPLEMENT), Sodium Butyrate (DIETARY_SUPPLEMENT), Tributyrin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06700785?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06700785's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI